|
US6187799B1
(en)
*
|
1997-05-23 |
2001-02-13 |
Onyx Pharmaceuticals |
Inhibition of raf kinase activity using aryl ureas
|
|
AU7585598A
(en)
*
|
1997-05-23 |
1998-12-11 |
Bayer Corporation |
Raf kinase inhibitors
|
|
PT986382E
(pt)
*
|
1997-05-23 |
2008-07-10 |
Onyx Pharma Inc |
Inibidores de raf-quinase
|
|
JP2001526230A
(ja)
|
1997-12-19 |
2001-12-18 |
スミスクライン・ビーチャム・コーポレイション |
ヘテロアリール置換イミダゾール化合物、その医薬組成物および使用
|
|
US7329670B1
(en)
|
1997-12-22 |
2008-02-12 |
Bayer Pharmaceuticals Corporation |
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
|
|
CA2315715C
(en)
*
|
1997-12-22 |
2010-06-22 |
Bayer Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
|
CA2315720A1
(en)
*
|
1997-12-22 |
1999-07-01 |
Bayer Corporation |
Inhibition of p38 kinase activity using substituted heterocyclic ureas
|
|
US7517880B2
(en)
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
|
US6858617B2
(en)
|
1998-05-26 |
2005-02-22 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
|
SE9802209D0
(sv)
*
|
1998-06-22 |
1998-06-22 |
Astra Pharma Inc |
Novel compounds
|
|
WO2000025791A1
(en)
|
1998-11-04 |
2000-05-11 |
Smithkline Beecham Corporation |
Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
|
|
UY25842A1
(es)
*
|
1998-12-16 |
2001-04-30 |
Smithkline Beecham Corp |
Antagonistas de receptores de il-8
|
|
DK1690853T3
(da)
*
|
1999-01-13 |
2010-06-07 |
Bayer Healthcare Llc |
Omega-carboxyaryl-substituerede diphenylurinstoffer til anvendelse som raf-kinaseinhibitorer
|
|
EP1140840B1
(en)
*
|
1999-01-13 |
2006-03-22 |
Bayer Pharmaceuticals Corp. |
-g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
HU225780B1
(en)
*
|
1999-01-13 |
2007-08-28 |
Bayer Corp |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors and phareutical compositions containing them
|
|
AU2004200566B2
(en)
*
|
1999-01-13 |
2006-08-17 |
Bayer Pharmaceuticals Corporation |
Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
|
|
ATE538794T1
(de)
*
|
1999-01-13 |
2012-01-15 |
Bayer Healthcare Llc |
Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
|
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
RU2319693C9
(ru)
*
|
1999-01-13 |
2008-08-20 |
Байер Копэрейшн |
Производные мочевины (варианты), фармацевтическая композиция (варианты) и способ лечения заболевания, связанного с ростом раковых клеток (варианты)
|
|
UA73492C2
(en)
|
1999-01-19 |
2005-08-15 |
|
Aromatic heterocyclic compounds as antiinflammatory agents
|
|
WO2000050425A1
(en)
*
|
1999-02-22 |
2000-08-31 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Polycyclo heterocyclic derivatives as antiinflammatory agents
|
|
JP2002538151A
(ja)
|
1999-03-02 |
2002-11-12 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
カテプシンの可逆的インヒビターとして有用な化合物
|
|
EP1690854A1
(en)
*
|
1999-03-12 |
2006-08-16 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Heterocyclic urea and related compounds useful as anti-inflammatory agents
|
|
EP1163236B1
(en)
*
|
1999-03-12 |
2005-11-09 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Aromatic heterocyclic compounds as anti-inflammatory agents
|
|
ID30176A
(id)
|
1999-03-12 |
2001-11-08 |
Boehringer Ingelheim Pharma |
Senyawa-senyawa yang bermanfaat sebagai zat anti-inflamasi
|
|
EP1466906A1
(en)
*
|
1999-03-12 |
2004-10-13 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Heterocyclic urea and related compounds useful as anti-inflammatory agents
|
|
WO2000061552A1
(en)
*
|
1999-04-07 |
2000-10-19 |
Santen Pharmaceutical Co., Ltd. |
N-SUBSTITUTED-N'-SUBSTITUTED UREA DERIVATIVE AND USE THEREOF AS TNF-α PRODUCTION INHIBITOR
|
|
US6573409B1
(en)
|
1999-07-02 |
2003-06-03 |
The Nutrasweet Company |
Process for the preparation of 3,3-dimethylbutanal
|
|
CA2378291A1
(en)
|
1999-07-07 |
2001-01-18 |
Astrazeneca Uk Limited |
Quinazoline derivatives
|
|
EP1200411B1
(en)
|
1999-07-09 |
2005-12-14 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Process for synthesis of heteroaryl-substituted urea compounds
|
|
US6420364B1
(en)
|
1999-09-13 |
2002-07-16 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compound useful as reversible inhibitors of cysteine proteases
|
|
US6407238B1
(en)
*
|
1999-10-29 |
2002-06-18 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Process of making substituted pyrazoles
|
|
CA2389360C
(en)
*
|
1999-11-16 |
2008-06-03 |
Steffen Breitfelder |
Urea derivatives as anti-inflammatory agents
|
|
AU1781601A
(en)
|
1999-11-23 |
2001-06-04 |
Smithkline Beecham Corporation |
3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors
|
|
DE60020595T2
(de)
|
1999-11-23 |
2006-03-16 |
Smithkline Beecham Corp. |
3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p38-kinase-inhibitoren
|
|
AU1782301A
(en)
|
1999-11-23 |
2001-06-04 |
Smithkline Beecham Corporation |
3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p39 kinase inhibitors
|
|
US6525046B1
(en)
|
2000-01-18 |
2003-02-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as antiinflammatory agents
|
|
US6608052B2
(en)
|
2000-02-16 |
2003-08-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
|
US7235551B2
(en)
|
2000-03-02 |
2007-06-26 |
Smithkline Beecham Corporation |
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
|
|
US6822093B2
(en)
|
2000-05-23 |
2004-11-23 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Synthesis of heteroarylamine intermediate compounds
|
|
US6635767B2
(en)
|
2000-05-23 |
2003-10-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Synthesis of heteroarylamine intermediate compounds
|
|
US6414013B1
(en)
*
|
2000-06-19 |
2002-07-02 |
Pharmacia & Upjohn S.P.A. |
Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention
|
|
EP1296973B1
(en)
|
2000-06-24 |
2008-11-05 |
AstraZeneca AB |
Guanidine derivatives of quinazoline for use in the treatment of autoimmune diseases
|
|
US6645990B2
(en)
|
2000-08-15 |
2003-11-11 |
Amgen Inc. |
Thiazolyl urea compounds and methods of uses
|
|
EP1506962B1
(en)
|
2000-10-20 |
2008-07-02 |
Eisai R&D Management Co., Ltd. |
Nitrogen-containing aromatic heterocycles
|
|
JP2004517080A
(ja)
|
2000-11-29 |
2004-06-10 |
グラクソ グループ リミテッド |
Ｔｉｅ−２および／またはｖｅｇｆｒ−２の阻害剤として有用なベンゾイミダゾール誘導体
|
|
US7235576B1
(en)
|
2001-01-12 |
2007-06-26 |
Bayer Pharmaceuticals Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
DE10109204A1
(de)
*
|
2001-02-26 |
2002-09-19 |
4Sc Ag |
Verbindungen zur Behandlung von Protozoen-Erkrankungen
|
|
EP1395548A1
(en)
|
2001-02-26 |
2004-03-10 |
4Sc Ag |
Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments
|
|
US7371763B2
(en)
|
2001-04-20 |
2008-05-13 |
Bayer Pharmaceuticals Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
|
JP2004530690A
(ja)
|
2001-05-16 |
2004-10-07 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
抗炎症性薬剤として有用なジアリールウレア誘導体
|
|
GB0112348D0
(en)
|
2001-05-19 |
2001-07-11 |
Smithkline Beecham Plc |
Compounds
|
|
WO2002096876A1
(en)
|
2001-05-25 |
2002-12-05 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Carbamate and oxamide compounds as inhibitors of cytokine production
|
|
PT1401825E
(pt)
|
2001-06-11 |
2009-10-23 |
Virochem Pharma Inc |
Compostos e métodos para o tratamento ou para a prevenção de infecções com flavivírus
|
|
US6603000B2
(en)
|
2001-07-11 |
2003-08-05 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Synthesis for heteroarylamine compounds
|
|
ATE360417T1
(de)
*
|
2001-07-11 |
2007-05-15 |
Boehringer Ingelheim Pharma |
Methode zur behandlung von zytokinvermittelten erkrankungen
|
|
EP1709965A3
(en)
|
2001-07-11 |
2006-12-27 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Methods of treating cytokine mediate diseases
|
|
US6924276B2
(en)
|
2001-09-10 |
2005-08-02 |
Warner-Lambert Company |
Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
|
|
US6825184B2
(en)
|
2001-10-18 |
2004-11-30 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
1,4-Disubstituted benzo-fused urea compounds
|
|
US7030141B2
(en)
*
|
2001-11-29 |
2006-04-18 |
Christopher Franklin Bigge |
Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
|
|
SI1580188T1
(sl)
|
2002-02-11 |
2012-02-29 |
Bayer Healthcare Llc |
Aril sečnine kot kinazni inhibitorji
|
|
US20040023961A1
(en)
*
|
2002-02-11 |
2004-02-05 |
Bayer Corporation |
Aryl ureas with raf kinase and angiogenisis inhibiting activity
|
|
SI1478358T1
(sl)
|
2002-02-11 |
2013-09-30 |
Bayer Healthcare Llc |
Sorafenib tozilat za zdravljenje bolezni, značilnih po abnormalni angiogenezi
|
|
WO2003072569A1
(en)
|
2002-02-25 |
2003-09-04 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
|
|
ATE349210T1
(de)
|
2002-07-09 |
2007-01-15 |
Boehringer Ingelheim Pharma |
Pharazeutische zusammensetzungen aus anticholinergica und p38 kinase hemmern zur behandlung von erkrankungen der atemwege
|
|
DE10257358A1
(de)
*
|
2002-12-09 |
2004-07-08 |
Bayer Healthcare Ag |
Substituierte Pyrrole
|
|
CN100413861C
(zh)
|
2002-12-10 |
2008-08-27 |
维勒凯姆制药股份有限公司 |
用于治疗或预防黄病毒感染的化合物
|
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
|
US7144911B2
(en)
|
2002-12-31 |
2006-12-05 |
Deciphera Pharmaceuticals Llc |
Anti-inflammatory medicaments
|
|
WO2004064730A2
(en)
|
2003-01-14 |
2004-08-05 |
Cytokinetics, Inc. |
Compounds, compositions and methods
|
|
GB0308511D0
(en)
*
|
2003-04-14 |
2003-05-21 |
Astex Technology Ltd |
Pharmaceutical compounds
|
|
CA2536964A1
(en)
*
|
2003-04-25 |
2004-11-11 |
Ortho-Mcneil Pharmaceutical, Inc. |
C-fms kinase inhibitors
|
|
EP1626714B1
(en)
|
2003-05-20 |
2007-07-04 |
Bayer Pharmaceuticals Corporation |
Diaryl ureas for diseases mediated by pdgfr
|
|
WO2004113352A1
(en)
*
|
2003-06-19 |
2004-12-29 |
Amedis Pharmaceuticals Ltd. |
Silylated heterocyclylurea derivatives as cytokine-inhibitors
|
|
EP1663978B1
(en)
|
2003-07-23 |
2007-11-28 |
Bayer Pharmaceuticals Corporation |
Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
|
|
EP1660474B1
(en)
|
2003-08-15 |
2008-10-29 |
AstraZeneca AB |
Substituted thiophenes and uses thereof
|
|
JP4303726B2
(ja)
|
2003-11-11 |
2009-07-29 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ウレア誘導体およびその製造方法
|
|
TW200530236A
(en)
|
2004-02-23 |
2005-09-16 |
Chugai Pharmaceutical Co Ltd |
Heteroaryl phenylurea
|
|
US20060211752A1
(en)
|
2004-03-16 |
2006-09-21 |
Kohn Leonard D |
Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression
|
|
DE102004015007A1
(de)
|
2004-03-26 |
2005-10-13 |
Bayer Healthcare Ag |
Substituierte Imidazole
|
|
WO2005110994A2
(en)
|
2004-04-30 |
2005-11-24 |
Bayer Pharmaceuticals Corporation |
Substituted pyrazolyl urea derivatives useful in the treatment of cancer
|
|
AU2005264988B2
(en)
|
2004-06-17 |
2011-09-22 |
Cytokinetics, Inc. |
Substituted urea derivatives for treating cardiac diseases
|
|
US20060035893A1
(en)
|
2004-08-07 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
|
|
JP4991544B2
(ja)
|
2004-08-23 |
2012-08-01 |
イエダ リサーチ アンド デベロップメント カンパニー リミテッド |
ストレス応答を媒介するためのペプチド阻害剤
|
|
US8969379B2
(en)
|
2004-09-17 |
2015-03-03 |
Eisai R&D Management Co., Ltd. |
Pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7=methoxy-6-quinolinecarboxide
|
|
BRPI0517567A
(pt)
*
|
2004-11-09 |
2008-06-17 |
Smithkline Beecham Corp |
composto ou um sal, solvato, ou derivado fisiologicamente funcional farmaceuticamente aceitável do mesmo, composição farmacêutica, usos de um composto ou um sal, solvato, ou derivado fisiologicamente funcional farmaceuticamente aceitável do mesmo e de uma composição farmacêutica, e, processo para preparar um composto
|
|
US7741479B2
(en)
|
2004-12-07 |
2010-06-22 |
Locus Pharmaceuticals, Inc. |
Urea inhibitors of MAP kinases
|
|
US7612200B2
(en)
|
2004-12-07 |
2009-11-03 |
Locus Pharmaceuticals, Inc. |
Inhibitors of protein kinases
|
|
PE20060777A1
(es)
|
2004-12-24 |
2006-10-06 |
Boehringer Ingelheim Int |
Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
|
|
DE102005008183A1
(de)
*
|
2005-02-23 |
2006-08-31 |
Bayer Healthcare Ag |
Heterocyclylamid-substituierte Imidazole
|
|
CA2601955C
(en)
|
2005-03-07 |
2012-07-10 |
Bayer Healthcare Ag |
Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer
|
|
BRPI0610283A2
(pt)
|
2005-05-13 |
2010-10-19 |
Virochem Pharma Inc |
composto, uso do mesmo na preparação de um medicamento para o tratamento ou prevenção de uma infecção por vìrus de hepatite c, composição farmacêutica e combinação farmacêutica
|
|
WO2007015578A1
(ja)
|
2005-08-02 |
2007-02-08 |
Eisai R & D Management Co., Ltd. |
血管新生阻害物質の効果を検定する方法
|
|
US7538223B2
(en)
|
2005-08-04 |
2009-05-26 |
Cytokinetics, Inc. |
Compounds, compositions and methods
|
|
EP1959960B1
(en)
|
2005-12-15 |
2013-04-10 |
Cytokinetics, Inc. |
Certain chemical entities, compositions and methods
|
|
US7825120B2
(en)
|
2005-12-15 |
2010-11-02 |
Cytokinetics, Inc. |
Certain substituted ((piperazin-1-ylmethyl)benzyl)ureas
|
|
EP1959962A2
(en)
|
2005-12-16 |
2008-08-27 |
Cytokinetics, Inc. |
Certain chemical entities, compositions, and methods
|
|
US7989455B2
(en)
|
2005-12-19 |
2011-08-02 |
Cytokinetics, Inc. |
Compounds, compositions and methods
|
|
JP2007254457A
(ja)
|
2006-02-23 |
2007-10-04 |
Daicel Chem Ind Ltd |
フラン化合物の製造法
|
|
CA2652442C
(en)
|
2006-05-18 |
2014-12-09 |
Eisai R & D Management Co., Ltd. |
Antitumor agent for thyroid cancer
|
|
EP2065372B1
(en)
|
2006-08-28 |
2012-11-28 |
Eisai R&D Management Co., Ltd. |
Antitumor agent for undifferentiated gastric cancer
|
|
US8962655B2
(en)
|
2007-01-29 |
2015-02-24 |
Eisai R&D Management Co., Ltd. |
Composition for treatment of undifferentiated gastric cancer
|
|
WO2008105408A1
(ja)
*
|
2007-02-26 |
2008-09-04 |
Santen Pharmaceutical Co., Ltd. |
ウレイド基とアミノカルボニル基を置換基として有する新規ピロール誘導体
|
|
BRPI0807717A2
(pt)
|
2007-04-20 |
2014-05-20 |
Deciphera Pharmaceuticals Llc |
Inibidores de quinase úteis para o tratamento de doenças mieloproliferativas e outras doenças proliferativas.
|
|
EP1992344A1
(en)
|
2007-05-18 |
2008-11-19 |
Institut Curie |
P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
|
|
CN101848895B
(zh)
|
2007-11-09 |
2013-10-23 |
卫材R&D管理有限公司 |
血管新生抑制物质和抗肿瘤性铂络合物的组合使用
|
|
EP3312269A1
(en)
|
2008-12-17 |
2018-04-25 |
The Scripps Research Institute |
Generation and maintenance of stem cells
|
|
ES2573515T3
(es)
|
2010-06-25 |
2016-06-08 |
Eisai R&D Management Co., Ltd. |
Agente antitumoral que emplea compuestos con efecto inhibitorio de cinasas combinados
|
|
MX2013009931A
(es)
|
2011-04-18 |
2013-10-01 |
Eisai R&D Man Co Ltd |
Agentes terapeuticos contra tumores.
|
|
WO2012160563A2
(en)
|
2011-05-23 |
2012-11-29 |
Yeda Research And Development Co. Ltd. |
Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
|
|
EP2714937B1
(en)
|
2011-06-03 |
2018-11-14 |
Eisai R&D Management Co., Ltd. |
Biomarkers for predicting and assessing responsiveness of thyroid and kidney cancer subjects to lenvatinib compounds
|
|
WO2013162027A1
(ja)
|
2012-04-27 |
2013-10-31 |
学校法人 慶應義塾 |
神経分化促進剤
|
|
US8461179B1
(en)
|
2012-06-07 |
2013-06-11 |
Deciphera Pharmaceuticals, Llc |
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
MX2015004979A
(es)
|
2012-12-21 |
2015-07-17 |
Eisai R&D Man Co Ltd |
Forma amorfa de derivado de quinolina y metodo para su produccion.
|
|
BR112015024678B1
(pt)
|
2013-04-02 |
2023-02-23 |
Oxular Acquisitions Limited |
Composto inibidor da cinase, formulação farmacêutica que compreende o mesmo, seus usos, processo para sua preparação e intermediários
|
|
NZ714049A
(en)
|
2013-05-14 |
2020-05-29 |
Eisai R&D Man Co Ltd |
Biomarkers for predicting and assessing responsiveness of endometrial cancer subjects to lenvatinib compounds
|
|
US9750723B2
(en)
|
2013-10-31 |
2017-09-05 |
Ohio University |
Prevention and treatment of non-alcoholic fatty liver disease
|
|
KR102346605B1
(ko)
*
|
2014-04-17 |
2021-12-31 |
재단법인 한국파스퇴르연구소 |
바이러스성 감염 치료용 화합물
|
|
WO2016010610A2
(en)
|
2014-07-18 |
2016-01-21 |
Ohio University |
Imidazole and thiazole compositions for modifying biological signaling
|
|
CN113683564A
(zh)
|
2014-08-28 |
2021-11-23 |
卫材R&D管理有限公司 |
高纯度喹啉衍生物及其生产方法
|
|
LT3263106T
(lt)
|
2015-02-25 |
2024-01-10 |
Eisai R&D Management Co., Ltd. |
Chinolino darinių kartumo sumažinimo būdas
|
|
CA2978226C
(en)
|
2015-03-04 |
2025-02-18 |
Eisai R&D Management Co., Ltd. |
COMBINATION OF A PD-1 ANTAGONIST AND A VEGFR/FGFR/RET TYROSINE KINASE INHIBITOR TO TREAT CANCER
|
|
CN107801379B
(zh)
|
2015-06-16 |
2021-05-25 |
卫材R&D管理有限公司 |
抗癌剂
|
|
RU2718048C2
(ru)
|
2015-08-20 |
2020-03-30 |
Эйсай Ар Энд Ди Менеджмент Ко., Лтд. |
Противоопухолевое терапевтическое средство
|
|
WO2018147275A1
(ja)
|
2017-02-08 |
2018-08-16 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
腫瘍治療用医薬組成物
|
|
RU2019134940A
(ru)
|
2017-05-16 |
2021-06-16 |
Эйсай Ар Энд Ди Менеджмент Ко., Лтд. |
Лечение гепатоцеллюлярной карциномы
|
|
BR112020015581A2
(pt)
|
2018-01-31 |
2021-02-02 |
Deciphera Pharmaceuticals, Llc |
terapia de combinação para o tratamento de tumores estromais gastrointestinais
|
|
EP3746060A1
(en)
|
2018-01-31 |
2020-12-09 |
Deciphera Pharmaceuticals, LLC |
Combination therapy for the treatment of mastocytosis
|
|
CN109734677A
(zh)
*
|
2019-03-07 |
2019-05-10 |
四川大学 |
抑制组蛋白赖氨酸甲基转移酶nsd2的小分子化合物及其应用
|
|
WO2021030405A1
(en)
|
2019-08-12 |
2021-02-18 |
Deciphera Pharmaceuticals, Llc |
Ripretinib for treating gastrointestinal stromal tumors
|
|
KR20220045189A
(ko)
|
2019-08-12 |
2022-04-12 |
데시페라 파마슈티칼스, 엘엘씨. |
위장관 기질 종양을 치료하는 방법
|
|
SMT202300467T1
(it)
|
2019-12-30 |
2024-01-10 |
Deciphera Pharmaceuticals Llc |
Formulazioni di inibitori di chinasi amorfi e loro procedimenti d’uso
|
|
CN118948773A
(zh)
|
2019-12-30 |
2024-11-15 |
德西费拉制药有限责任公司 |
1-(4溴-5-(1乙基-7-(甲氨基)-2侧氧基-1,2-二氢-1,6-萘啶-3基)-2氟苯基)-3-苯基脲的组合物
|
|
CN113717148B
(zh)
*
|
2020-05-25 |
2023-09-05 |
上海医药工业研究院 |
一种杂芳酰胺类化合物、其制备方法及应用
|
|
US11779572B1
(en)
|
2022-09-02 |
2023-10-10 |
Deciphera Pharmaceuticals, Llc |
Methods of treating gastrointestinal stromal tumors
|